Every one of those 1 sits in a single category, acquisition. Advanced Medical Solutions Group Plc is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention H.B. Fuller Co., all published on June 25, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about H.B. Fuller Co.
Every one of those 1 sits in a single category, acquisition. Advanced Medical Solutions Group Plc is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention H.B. Fuller Co., all published on June 25, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering H.B. Fuller Co.. Shared-story counts are live from our verified record — not editorial picks.
The biotech sector sees heightened M&A activity as H.B. Fuller acquires UK tissue-repair specialist AMS for £659M. The all-cash deal brings a branded pipeline of cyanoacrylate surgical adhesives and alginate wound dressings under industrial ownership, with immediate earnings accretion.